Potentiating the Cytotoxic Activity of a Novel Simvastatin-Loaded Cubosome against Breast Cancer Cells: Insights on Dual Cell Death via Ferroptosis and Apoptosis
Yara E Elakkad,Shimaa Nabil Senousy Mohamed,Nermeen Z Abuelezz
DOI: https://doi.org/10.2147/BCTT.S336712
2021-12-14
Breast Cancer: Targets and Therapy
Abstract:Yara E Elakkad, 1 Shimaa Nabil Senousy Mohamed, 2 Nermeen Z Abuelezz 3 1 Department of Pharmaceutics, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, Giza, Egypt; 2 Biochemistry Division, Chemistry Department, Center of Basic Sciences, Misr University for Science and Technology, Giza, Egypt; 3 Biochemistry Department, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, Giza, Egypt Correspondence: Nermeen Z Abuelezz Biochemistry Department, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, Giza, Egypt Tel +20 1005677429 Email Purpose: Female breast cancer is the most prevalent cancer worldwide. Emerging evidence shows that simvastatin (SIM) has promising anticancer activities. However, the underlying mechanisms are not fully elucidated. Increasing reports imply statins can modulate ferroptosis through disrupting reactive oxygen species (ROS) and glutathione peroxidase enzyme (GPX4) levels. However, whether ferroptosis contributes to SIM anticancer activity, especially regarding GPX4 is unclear. Moreover, poor aqueous SIM solubility hinders its delivery in adequate levels to tumor sites. Meanwhile, cubosomes are biocompatible nanocarriers that enhance lipophilic drug delivery. Therefore, in this study, we formulated a novel SIM-loaded cubosome (SIM-CB) and analyzed its cytotoxic activity on MCF-7 cancer cells in comparison with free SIM. Methods: The present study tested the cytotoxic activity of SIM-CB on MCF-7 cells, in comparison with SIM using sulphorhodamine assay. We analyzed SIM-CB effect on apoptosis and cell cycle using flowcytometry, and investigated its effect on Bcl-2, caspase 3, ROS, reduced glutathione (GSH), lipid peroxides and GPX4 enzyme. Finally, we tested the persistence of SIM-CB apoptosis and ferroptosis activities on MCF-7 cells in presence of vitamin E, a potent antioxidant and ferroptosis inhibitor. Results: SIM-CB was successfully formulated at the nano size. SIM-CB significantly increased simvastatin therapeutic activity, with IC 50 of SIM-CB 52% lower than SIM. 95% CI [1.8, 2.7], SD = 0.34 for SIM-CB, and [4.1, 5.2], SD = 0.45 for SIM. Compared with free SIM, SIM-CB doubled total deaths and increased apoptosis (p < 0.05). Moreover, SIM-CB remarkably increased caspase-3, ROS, and lipid peroxide levels but decreased antiapoptotic Bcl-2 protein, GSH, and GPX4 compared with free SIM. Notably, SIM-CB elicited a high distinguished resistance against the inhibitory effects of vitamin E. Conclusion: To the best of our knowledge, this study is the first to present SIM-CB as a promising means to enhancing the therapeutic potential of simvastatin against breast cancer cells, through potentiating both apoptosis and ferroptosis. Keywords: anticancer, MCF-7 breast cancer cells, statins, nanoparticle, cell death Female breast cancer is the most prevalent cancer type and one of the top three deadliest cancers worldwide. 1 Despite the remarkable progress in breast cancer treatment, considerable number of cases still suffer from prompt recurrence, poor prognosis and metastasis. 2 Therefore, extensive efforts are ongoing to integrate novel agents that can tackle these challenges. Statins are drugs widely used to control hypercholesterolemia, through inhibiting the rate limiting (HMG-COA reductase step) of cholesterol synthesis. Recent studies spot the distinguished potential of lipophilic statins, against different cancer types. 3,4 In agreement, simvastatin (SIM) use is reported to decrease the risk of breast cancer progression to higher stages. 5,6 While other basic studies reveal that SIM potentiates the cytotoxic effects of anticancer drugs against MCF-7 cells. 7 The cytotoxic potential of SIM has been explained mostly by its ability to induce apoptosis and modulate protein cascades that regulate the apoptotic pathway in tumor cells. 8–10 However, to date, the mechanisms underlying SIM cytotoxic activity are not fully clarified. Ferroptosis is currently emerging as a significant type of programmed cell death that encounters cancer progression and possible anticancer activity. 11 Where, on the molecular level, the proper levels and functionality of reduced glutathione (GSH) and subcellular phospholipid hydroperoxide glutathione peroxidase (GPX4) enzyme are the core of keeping ferroptosis in check. Whereas ferroptosis inducers act to reduce or destabilize GPX4 enzyme and deplete GSH stores. 12 Such changes consequently enhance the membranous lipid peroxidation and cause the accumulation of react -Abstract Truncated-